Rubio-Camacho, M., Encinar, J., Martinez-Tome, M., Esquembre, R., & Mateo, C. (2020). The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug.
Citación estilo ChicagoRubio-Camacho, M., JA Encinar, MJ Martinez-Tome, R. Esquembre, y CR Mateo. The Interaction of Temozolomide With Blood Components Suggests the Potential Use of Human Serum Albumin As a Biomimetic Carrier for the Drug. 2020.
Cita MLARubio-Camacho, M., et al. The Interaction of Temozolomide With Blood Components Suggests the Potential Use of Human Serum Albumin As a Biomimetic Carrier for the Drug. 2020.
Precaución: Estas citas no son 100% exactas.